RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

The CDC recommends everyone ages 6 months and older get an updated COVID-19 and Flu vaccines. The RSV vaccine is recommended ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...